Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-26

Clinical Trial Update: A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

View source ↗

Summary

A multicenter clinical trial is evaluating the efficacy and safety of avapritinib for metastatic or unresectable gastrointestinal stromal tumor and is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avapritinib (avapritinib)

Snippet

Sponsor: Xinhua Zhang, MD | Conditions: Gastrointestinal Stromal Tumors, Unresectable Solid Tumor | Status: RECRUITING